|
GenVec Inc - Premium Company Profile (Datamonitor)
Market: Healthcare and Medical
Published Date: 14/12/2007
Market Research Report Title: GenVec Inc - Premium Company Profile
Table of Contents: View
Report Type: Company Profile
Country: Global
Number of Pages: 53
|
Enquire about Report |
Summary: Introduction
GenVec is a clinical-stage biopharmaceutical company utilizes its proprietary platform, adenovector technology. It′s collaborations with National Institute of Health, US Navy and US Department of Agriculture to use its delivery platform to develop vaccines against HIV, influenza, malaria, and foot and mouth disease have established it as potential player in Vaccine market.
Scope
Contains corporate strategy, value chain presence and SWOT AnalysisProvides detailed business description, segment analysis, 5-year financial trends, key products and key competitorsIncludes information on suppliers/ partners, shareholding structure and key employees with biographiesHighlights
GenVec is a clinical-stage biopharmaceutical company that specializes in using adenovector-based vectors to deliver gene-based therapies for the treatment of various cancers, including pancreatic, head and neck, and rectal cancer.The company′s lead candidate, TNFerade, is in Phase II/III clinical trial for the treatment of pancreatic cancer.The key elements of the company′s business strategy include: advancing the clinical development of its product candidate, TNFerade; continue application of its proprietary adenovector technology to develop new products and strengthening the company′s financial and market position through its funded vaccine programs.The company′s total revenues increased at a CAGR of 22.5% during 2002-2006, from $8.4 million to $18.9 million. This represents an absolute total growth of +$10.5 million for total revenues. The company′s only contributor to revenue growth during 2002-2006 was revenues from license, collaboration and others.Reasons to Purchase
Access all the important information and analysis on the company in a single reportUnderstand company′s strengths, weaknesses, opportunities and threats along with business strategy and value chainGain access to company′s adjusted five year financial data along with key ratios and market capitalization
Reports are normally delivered on the same day, via email, if purchased by debit/credit card. Reports purchased by invoice will be released when payment has been received. When you place an order through Google Checkout, Google Checkout will display a price approximation in your local currency. Keep in mind that you'll still be charged in the currency displayed on companiesandmarkets.com. Your debit/credit card company might convert the charge to your local currency and may also add additional fees that are not reflected in the approximate price displayed.
www.companiesandmarkets.com is a central source of market research reports from the world’s leading analysts and report publishers. Companiesandmarkets.com contains a comprehensive range of specialised market research reports from leading publishers for all market sectors.
